Aerovate Therapeutics, Inc. - Common Stock (NQ:AVTE)

2.680 UNCHANGED

Last Price Updated: 4:00 PM EDT, Apr 28, 2025 Add to My Watchlist

Price and Volume

Volume	0
Open	2.680
Bid (Size)	2.650 (3)
Ask (Size)	2.700 (20)
Prev. Close	2.680
Today's Range	2.680 - 2.680
52wk Range	N/A - N/A
Shares Outstanding	28,985,019
Dividend Yield	3,134.33%

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

The trading volume of these stocks is deviating from the norm in today's session. ↗

April 28, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

Small Cap News Movers: Your Daily Digest of Stocks Making Moves on Market News ↗

April 15, 2025

Via Stocktwits

Performance

More News

Aerovate Therapeutics Stock Bucks Broader Market Sell-Off Over Dividend Announcement: Stock Rises But Retail’s Unmoved ↗

April 07, 2025

Via Stocktwits

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates TGI, AVTE, HEES, AMPY on Behalf of Shareholders

April 02, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates FNA, AVTE, RSLS on Behalf of Shareholders

March 23, 2025

From Halper Sadeh LLC

Via GlobeNewswire

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE

March 21, 2025

From Kahn Swick & Foti, LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, AVTE, GB on Behalf of Shareholders

February 26, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates IVAC, AVTE, QTRX on Behalf of Shareholders

February 17, 2025

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER NOTICE: Halper Sadeh LLC Investigates MHLD, IPG, AVTE on Behalf of Shareholders

January 26, 2025

From Halper Sadeh LLC

Via GlobeNewswire

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders

December 28, 2024

From Halper Sadeh LLC

Via Business Wire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVTE, PFIE, EMKR on Behalf of Shareholders

December 06, 2024

From Halper Sadeh LLC

Via GlobeNewswire

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates PSTX, AVTE, GATO on Behalf of Shareholders

December 04, 2024

From Halper Sadeh LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Gatos Silver, Inc. (NYSE - GATO), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE)

December 04, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Poseida Therapeutics, Inc. (Nasdaq – PSTX), Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc.

November 26, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

AEROVATE THERAPEUTICS INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Aerovate Therapeutics, Inc. - AVTE

November 04, 2024

From Kahn Swick & Foti, LLC

Via Business Wire

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Air Transport Services Group, Inc. (Nasdaq– ATSG), Micropac Industries, Inc. (OTC - MPAD), Aerovate Therapeutics, Inc. (Nasdaq - AVTE), Outbrain Inc. (Nasdaq - OB)

November 04, 2024

From Brodsky & Smith LLC

Via GlobeNewswire

“The Future is Bright: Peraso Inc. (NASDAQ: PRSO) Expands Technology for Tactical Applications in High-Demand Industries – More Stocks Inside…”

October 31, 2024

Via AB Newswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 31, 2024

Via Benzinga

AVTE Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aerovate Therapeutics, Inc. Is Fair to Shareholders

October 31, 2024

From Halper Sadeh LLC

Via Business Wire

Shareholder Alert: Ademi LLP Investigates Whether Aerovate Therapeutics, Inc. Is Obtaining a Fair Price for Its Public Shareholders

October 31, 2024

From Ademi LLP

Via Business Wire

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 31, 2024

Via Benzinga

Aerovate Therapeutics and Jade Biosciences Announce Merger Agreement

October 31, 2024

From Jade Biosciences

Via GlobeNewswire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

October 01, 2024

Via Benzinga

AVTE Stock Earnings: Aerovate Therapeutics Misses EPS for Q2 2024 ↗

August 12, 2024

Via InvestorPlace

Aerovate Therapeutics to Explore Strategic Alternatives

July 08, 2024

From Aerovate Therapeutics, Inc.

Via GlobeNewswire

Frequently Asked Questions

Is Aerovate Therapeutics, Inc. - Common Stock publicly traded?

Yes, Aerovate Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Aerovate Therapeutics, Inc. - Common Stock trade on?

Aerovate Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Aerovate Therapeutics, Inc. - Common Stock?

The ticker symbol for Aerovate Therapeutics, Inc. - Common Stock is AVTE on the Nasdaq Stock Market

What is the current price of Aerovate Therapeutics, Inc. - Common Stock?

The current price of Aerovate Therapeutics, Inc. - Common Stock is 2.680

When was Aerovate Therapeutics, Inc. - Common Stock last traded?

The last trade of Aerovate Therapeutics, Inc. - Common Stock was at 04/28/25 04:00 PM ET

What is the market capitalization of Aerovate Therapeutics, Inc. - Common Stock?

The market capitalization of Aerovate Therapeutics, Inc. - Common Stock is 77.68M

How many shares of Aerovate Therapeutics, Inc. - Common Stock are outstanding?

Aerovate Therapeutics, Inc. - Common Stock has 78M shares outstanding.